Skip to content
10-K

Annual Report

IDEAYA Biosciences, Inc. IDYA

0001193125-26-054533

← back to feed
Filed
Feb 17, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 13, 2026 87.81M sh
Shares Diluted FY 2025 · Dec 31, 2025 88.49M sh
Shares Diluted FY 2025 · Dec 31, 2024 81.68M sh
Shares Diluted FY 2025 · Dec 31, 2023 57.52M sh
Capex FY 2025 · Dec 31, 2025 $2.37M
Capex FY 2025 · Dec 31, 2024 $3.86M
Capex FY 2025 · Dec 31, 2023 $2.37M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$71.1M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$247.58M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$115.22M
Cash And Equivalents FY 2025 · Dec 31, 2025 $112.83M
Cash And Equivalents FY 2025 · Dec 31, 2024 $84.38M
Cash And Equivalents FY 2025 · Dec 31, 2023 $157.02M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.02B
Stockholders Equity FY 2025 · Dec 31, 2024 $1.06B
Stockholders Equity FY 2025 · Dec 31, 2023 $621.09M
Stockholders Equity FY 2025 · Dec 31, 2022 $349.46M
Current Liabilities FY 2025 · Dec 31, 2025 $58.82M
Current Liabilities FY 2025 · Dec 31, 2024 $46.07M
Total Liabilities FY 2025 · Dec 31, 2025 $86.39M
Total Liabilities FY 2025 · Dec 31, 2024 $64.94M
Current Assets FY 2025 · Dec 31, 2025 $666.73M
Current Assets FY 2025 · Dec 31, 2024 $689.71M
Total Assets FY 2025 · Dec 31, 2025 $1.11B
Total Assets FY 2025 · Dec 31, 2024 $1.12B
Eps Diluted FY 2025 · Dec 31, 2025 −$1.28
Eps Diluted FY 2025 · Dec 31, 2024 −$3.36
Eps Diluted FY 2025 · Dec 31, 2023 −$1.96
Eps Basic FY 2025 · Dec 31, 2025 −$1.28
Eps Basic FY 2025 · Dec 31, 2024 −$3.36
Eps Basic FY 2025 · Dec 31, 2023 −$1.96
Sga Expense FY 2025 · Dec 31, 2025 $63.32M
Sga Expense FY 2025 · Dec 31, 2024 $39.3M
Sga Expense FY 2025 · Dec 31, 2023 $28.31M
Rd Expense FY 2025 · Dec 31, 2025 $314.7M
Rd Expense FY 2025 · Dec 31, 2024 $294.67M
Rd Expense FY 2025 · Dec 31, 2023 $129.51M
Net Income FY 2025 · Dec 31, 2025 −$113.7M
Net Income FY 2025 · Dec 31, 2024 −$274.48M
Net Income FY 2025 · Dec 31, 2023 −$112.96M
Operating Income FY 2025 · Dec 31, 2025 −$159.31M
Operating Income FY 2025 · Dec 31, 2024 −$326.98M
Operating Income FY 2025 · Dec 31, 2023 −$134.43M
Revenue FY 2025 · Dec 31, 2025 $218.71M
Revenue FY 2025 · Dec 31, 2024 $7M
Revenue FY 2025 · Dec 31, 2023 $23.39M